Following the entry into force of Regulation (EU) 2020/217, by which titanium dioxide in the form of a powder containing 1 percent or more of particles with a diameter of 10 μm or less was recognized as a carcinogen for inhalation (H351), and the harmonization of the classification and labeling of the substance, a consortium of manufacturers, importers, downstream users, and distributors of titanium dioxide brought an action for annulment of the decision.

In its judgment that consists of three joined cases, the General Court nullified the regulation on the classification and labeling of titanium dioxide.

For more information you can consult this link.

You can freely contact us to learn more about your situation and request our support.

Cookie Policy
Manage Cookies
Cookies help us remember you, personalize your experience, deliver personalized commercial offers and show you more things we think you will like. For more information on cookies, please visit our cookie policy page.
Privacy Settings
These cookies enable us to offer you a personalized experience based on your navigation: